These updates are listed according to the TAM Subgroup that ratifies them. The TAM Subgroup meets every 2 months.

'Latest updates' is a collection of those amendments that have been published while awaiting ratification at the next TAM Subgroup. 

Latest updates

New Guidance:

  • Items will be added when published. 

Major updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.

  • Items will be added when published. 

Minor updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.
These items will be ratified at the next TAMSG. 


Reviewed with no changes: 

  • Items will be added when published. 

Removed Guidance:

  • Items will be added when removed. 

February 2026 TAMSG

New Guidance

  • Items will be added as published. 

Major updates

To view the changes to the guidance, see the 'What's new' section of each guideline.

Influenza Treatment (Antimicrobial) | Right Decisions

  • UKHSA updated national guidance on influenza treatment and prophylaxis on 4th November 2025 from which many of these changes have been taken. 
  • The list of patients at risk of severe influenza or hospitalisation along with examples of patients regarded as being immunosuppressed have been expanded. 
  • Recommendation for use of antibiotics for secondary bacterial infection in a patient with influenza should be based on clinical assessment. 
  • IV zanamivir has been in short supply in recent years so should only be considered if oral or enteral oseltamivir or inhaled zanamivir cannot be administered, noting the evidence for efficacy of antivirals in severe influenza is based on oseltamivir.   
  • NHS Highland Renal Team recommend using Renal Drug Database dosing advice for oseltamivir in renal impairment or renal replacement therapies. 
  • Dosing in renal impairment has been added to the guidance.   

Warfarin, DOACs and antiplatelets in adults undergoing surgery or invasive procedures (Guidelines) | Right Decisions

Amendment to table: Time between administration of DOAC and performance of block/catheter insertion; and between removal of catheter and next dose of DOAC:

  • Time between last dose of DOAC and catheter insertion: specific timings have been removed and replaced with statement: 'This information is currently under review. Leave at least a minimum of 48 hours (72 hours for dabigatran). If in doubt, contact consultant anaesthetist for advice.'

Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke (Guidelines) | Right Decisions

  • From the 2nd of February 2026 patients diagnosed with a TIA or ischaemic stroke will undergo genetic testing for CYP2C19 variants, and therefore clopidogrel resistance. Patients who are identified as poor metabolisers of clopidogrel will require alternative antiplatelets to be prescribed as part of their acute and long term stroke treatment. Guidance on the prescribing of antiplatelets has been updated on TAM. Patients and prescribers will be informed of any change to treatment and their metaboliser status recorded on their records alongside allergies. 

Minor updates

To view the changes to the guidance, see the 'What's new' section of each guideline.
These items will be ratified at the next TAMSG. 

Refugee and Asylum seeker support (Resources) | Right Decisions

  • Point of Contact details updated
  • Links added: WHO, Third Sector Organisations

Hyperkalaemia: Primary Care (Guidelines) | Right Decisions

  • Removed: Note regarding renal patients tolerance to high potassium levels. 
  • Reworded information re potassium-containing laxatives as a cause of hyperkalaemia acknowledging instead their potassium content: 'To note that macrogol laxatives (Laxido/Movicol) have <1mmol K+ per sachet'. 

Dietetic service referral (Guidelines) | Right Decisions

  • Removed as no longer available:Active Health — Velocity Café & Bicycle Workshop (velocitylove.co.uk)
    A free and confidential one-to-one advice service for people (aged 16+) living in the NHS Highland area who would like to become more active to help their physical and/or mental health. GPs or other healthcare professional can refer, or patients can self-refer
  • email address updated to: northhighlandcommunitydietetics@nhs.scot

Assessment of carotid artery stenosis following TIA and minor stroke and referral for carotid endarterectomy (Guidelines) | Right Decisions

  • Removed retired doctors contact details

Anticoagulant switching (Guidelines) | Right Decisions

  • The term 'unfractionated heparin' is changed to 'heparin' as per BNF update. 

Parkinson's disease (Guidelines) | Right Decisions

  • Added: recommendation of ipratropium bromide spray for sialorrhea [off-label] 
  • Link to SIGN157 guideline and Annex 4

Cardiac rehabilitation (Guidelines) | Right Decisions

  • Updated phone number for the department
  • Updated CR Discharge letter/booklet
  • Addition of new website link under "Patient information" section

Exercise after Stroke Pathway (Guidelines) | Right Decisions

  • Updated from The Stroke Improvement Programme (2021) to The Stroke Improvement Programme (2024)
  • Added link to The Stroke Association : www.stroke.org.uk 

Rape and sexual assault (Guidelines) | Right Decisions

  • Added: Signposting for under 16s to the national child protection guidance. 

Sodium zirconium in chronic hyperkalaemia (Guidelines) | Right Decisions

  • Prescribing guidance for SZC in chronic hyperkalaemia flow chart formatted: no changes to content.

Abnormal liver blood results referral pathway (Over 16’s) (Guidelines) | Right Decisions

High consequence infectious disease (HCID) pathway (Guidelines) | Right Decisions

  • Minor modifications for clarity, including to action cards.
    • Action card source document is now HCID-NHSH patient pathway version 1.2_210126
    • HCID clinical pathway: Quick reference guide: Suspected HCID next steps: Added: 'Key personnel informed of the patient', 'See: communication cascade'. Removed: 'Arrange transfer' & duplication of information.
    • Infection specialist assessment: Details added re communication with lead clinician
    • Removed as duplication: 'NHS Highland triage algorithm or national resources High consequence infectious diseases (HCID) can be used to assess risk for HCID'.
    • Patient designated as 'suspected HCID': next steps: Added: List of roles who have action cards. Removed as duplication: 'Roles and responsibilities'
    • Section removed as duplication: 'Ongoing management of suspected HCID Roles, responsibilities and actions'
    • Action Card 1: Name changed from: Suspected HCID ongoing management: Attending Health Care Professional, To: Suspected HCID ongoing management: Lead clinician for the patient (Usually GP or Consultant)
  •  Minor modifications made to improve the readability of the guidance:
    • Direct contact details for Argyll & Bute Infection and Control nurses have been removed. Generic contact details to be added. 
    • Advice regarding patient with suspected HCID using ward phone (to be wrapped in plastic) has been added. 
    • Advice added under 'History taking and 'remote assessment' on when to leave the pathway (if no concern re HCID).
    • Additional face to face assessment information has been removed as extraneous information. 
    • Separate section on patient transportation removed as this information is elsewhere in the guidance. 
    • Section: 'Ongoing management of suspected HCID: Roles, responsibilities and actions' has been amended with explanatory text included for the terms used. 
    • Terms 'clean' and 'dirty' have been removed as these terms are obsolete. 

Community Acquired Pneumonia (CAP) (Antimicrobial) | Right Decisions

  • added under Duration Note section: 'Oral switch should be guided by positive Microbiology results, if available.  Options given are empiric.'
  • corrected dosing for CAP with history of recent foreign travel from Oral/IV azithromycin 500mg twice daily to once daily.
  • added in duration section of CAP Severe Level 2 or 3 CARE:  '(empiric)' after oral switch.
  • added in duration section of CAP Severe in non-severe penicillin allergy:  '(empiric)' after oral switch.

Prevention of skeletal-related events in cancer patients (Guidelines) | Right Decisions

  • The term, sodium clodronate, has been changed to clodronate disodium throughout as per BNF update.

Termination of pregnancy (Guidelines) | Right Decisions

  • Email address on guideline updated to nhsh.unplannedpregnancy@nhs.scot 

Depot and long-acting antipsychotic injections (Guidelines) | Right Decisions

 Olanzapine LAI protocol has been updated.

  • Section 1: Circumstances where olanzapine LAI may be considered for use in NHSH changed to include any patient transferred as continuation of treatment rather than only transfer from a medium/low secure facility
  • Section 2: Authorisation process changed from IPTR to PACS as per the updated access to medicine procedure and clarity regarding what needs specified on a T3, which was confirmed by the Mental Welfare Commission in 2022.
  • Section 3: New training site details following manufacturer move from Eli.Lilly to Neon HC. Bullet points added
  • Section 4.1: Definition of healthcare facility expanded, as per information from the manufacturer.
  • Section 4.3: Added information on what should be done if a patient refuses to stay for the three hour monitoring period and updated links to rapid tranquilisation policy and toxbase monograph.
  • Appendix 1: reviewed to include the most recent data about the incidence of post injection syndrome and how this presents

Highland Eating Disorder Service (HEDS) & Medical Emergency Eating Disorder (MEED) (Guidelines) | Right Decisions

  • Referral pathway to HEDS: Quick reference guide flow chart re-formatted

CT scanning in acute stroke patients (at home or Community Hospital) (Guidelines) | Right Decisions

  • Admission for scan time reduced from 12 hours to 4 hours in line with Stroke Standard of 2026 Guidance.  Change from Jan 2026
  • Line added to now read "A CT scan is used to distinguish between ischaemic and haemorrhagic stroke. Making this distinction is important to enable appropriate, suitability for thrombolysis / thrombectomy treatment and  secondary prevention"
  • Under "Referral for CT scan" option for "own transport" added.

Catheter maintenance solutions (Guidelines) | Right Decisions

  • Catheter maintenance solutions flowchart uploaded as a printable version

Stable angina management (Guidelines) | Right Decisions

  • Changed from: Referrals to the RACPC can be made either through CCU directly or via SCI gateway
    Changed to: Referrals to the RACPC are made via SCI gateway
  • Patient letter added

Heart failure (Patient information) | Right Decisions

  • Links reviewed by author and updated.

Armed forces and veterans (Resources) | Right Decisions

  • Added: Section on Training
  • Added: Information about Veterans In-Service Injury Network
  • Added: List of policy areas that the AFC duty is to be extended to.
  • Updated: Veterans welfare scheme email

Silver diamine fluoride (Dental Guidelines) | Right Decisions

  • Silver diamine fluoride use aligns with the SDCEP guidelines on management of dental caries in children
  • Guideline reflects the use of the aqueous version of the silver diamine fluoride
  • Statement added re: potassium iodide being optional to silver diamine fluoride 
  • Statement added: While silver diamine fluoride is an off label treatment for dental caries in the UK, it is approved for this use in other countries, which provides a stronger justification for its use.

Treatment of bacterial meningitis following admission to secondary care (Antimicrobial) | Right Decisions

  • The section has been reviewed with the additional note to consider risk factors for TB meningitis and clarification of some doses, in line with BNFc.

Smoking cessation (Guidelines) | Right Decisions


Reviewed with no changes


Removed Guidance

  • COVID-19: High Flow Nasal Oxygen (Raigmore Hospital) (Guidelines)
  • COVID-19: Maternity and Obstetrics (Guidelines)
  • COVID-19: Diabetes in Pregnancy (Guidelines)

December 2025 TAMSG

 

Major updates

To view the changes to the guidance, see the 'What's new' section of each guideline.


Minor updates

To view the changes to the guidance, see the 'What's new' section of each guideline.


Reviewed with no changes


Removed Guidance

    • Amputation pain (Raigmore in-patient) (Guidelines)

October 2025 TAMSG

*New Guidance* (ratified at previous TAMSG):


*Major updates* (ratified at previous TAMSG): 

To view the changes to the guidance, see the 'What's new' section of each guideline.


Minor updates (awaiting ratification at next TAMSG): 

To view the changes to the guidance, see the 'What's new' section of each guideline.


Reviewed with no changes: 


Removed Guidance:

  • Proton pump inhibitor (PPI) selection and administration in children (Paediatric Guidelines) - Guidance reviewed and incorporated into TAM336 Infant feeding difficulties.
  • Lyme disease (Antimicrobial). Removed and content incorporated into Lyme disease (Guidelines)
  • HIV referral pathway (Guidelines). Replaced and incorporated into: Human immunodeficiency virus (HIV) (Guidelines) | Right Decisions
  • HIV instant home testing pathway (Guidelines). Replaced and incorporated into: Human immunodeficiency virus (HIV) (Guidelines) | Right Decisions
  • COVID-19: Oxygen flowcharts (Guidelines)
  • COVID-19: Patient information
  • COVID-19: Fingers & Toes (Guidelines)
  • COVID-19: Trial medication (Guidelines)

August 2025 TAMSG

New Guidance: 

Updated Guidance: 

To view the changes to the guidance, see the 'What's new' section of each guideline.

Removed guidance:

February 2025 TAMSG

New Guidance: 

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Guidance reviewed with no changes:

Guidance removed and archived:

  • COVID-19: When to refer to Infectious Diseases Team (In-patient) (Guidelines)
  • COVID-19: Aerosol Generating Procedures (Guidelines) 
  • Sleep onset difficulties (Paediatric Guidelines)
  • CKD: Screening and diagnosis & CKD: Management. These have been combined into the one CKD guideline. 
  • TAM515: Lymphoedema, Assessing vascular status (Guidelines) Guideline not developed as awaiting national guidance. 

2024

January 2024

Updated Guidance


February 2024

Updated guidance

Removed guidance

  • Introduction to treatment of low electrolytes as the information is within the guidance

March 2024

New guidance

  • Haematology Full guideline suite reviewed with updates to guidelines and new guidelines added: 
    • Thrombocytopenia
    • Neutropenia
    • Neutrophilia
    • Lymphocytosis
    • Eosinophilia
    • Basophilia
    • Monocytosis
    • Splenomegaly
    • Lymphadenopathy
    • Elevated plasma viscosity
    • Iron deficiency
    • Hyperferritinaemia
    • Abnormal coagulation screen and bruising
    • VTE and travel
    • Blood parasite investigation
  • ADHD Guidelines

Updated guidance

Removed guidance

  • ADHD Pilot Pathway 
  • Post partum haemorrhage 
  • Physical monitoring with mental health

April 2024

New Guidance

Updated Guidance (with changes)

Updated Guidance (no changes)

Removed Guidance 

  • COVID115 Management of surgical patients who decline a COVID19 test
  • AMT136 Prophylaxis following tick bite
  • AMT137 Erythema migrans (EM) and/or non-focal symptoms (eg 'flu-like' symptoms)
  • AMT138 Lyme disease affecting the cranial nerves or peripheral nervous system
  • AMT139 Lyme disease affecting the central nervous system
  • AMT140 Lyme disease arthritis, Acrodermatitis chronic atrophicans
  • AMT141 Lyme carditis: haemodynamically stable
  • AMT142 Lyme carditis: haemodynamically unstable

May 2024

New Guidance:

Updated Guidance: 

Removed Guidance:

  • Anticoagulant recommendations. This is replaced with: Warfarin.

June 2024

New guidance:

Updated guidance: 

Guidance reviewed with no changes: 

Removed guidance: 

  • Referral to clinical Psychology (Guidelines)
  • Orlistat Frequently Asked Questions (Patient information)
  • Bariatric Surgery Frequently Asked Questions (Patient information)
  • Non-steroidal anti-inflammatory drugs (NSAIDS) (Guidelines)
  • Self Help Service - patient information leaflet (Guidelines)

July 2024

New guidance: 

Updated Guidance: 

To view the changes to guidance, see the 'What's new' section of each guideline. 

Removed guidance: 

  • Hospital in-patients admitted with symptomatic COVID-19 infection (Guidelines)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection (Guidelines)
  • Highest Risk List: COVID-19 (Guidelines):
    Replaced by: Risk factors for progression to severe COVID-19 infection | Right Decisions (scot.nhs.uk)
  • Community Pharmacy (Resources):
    Archived as information now available on CP website. 
  • Allergy (Paediatric guidelines):
    Replaced by Food allergy referral and Egg allergy guidelines. 
  • Epidural (Paediatric Guidelines) | Right Decisions (scot.nhs.uk)

August 2024

New Guidance:

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline. 

Guidance reviewed with no changes:


September 2024

New guidance: 

Updated guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Archived guidance: 


October 2024

Updated guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Guidance updated with no amendments:

Guidance removed and archived:

  • Polyarthritis / Polyarthropathy

November 2024

New Guidance:

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.


December 2024

Included in Feb 2025 updates. 

2023

January 2023:

New guidance

  • TAM535 ADHD pilot pathway

Amended guidance 

  • TAM528 Delirium management
  • TAM281 Parkinsons disease
  • TAM148 Achieving control in type 2 diabetes
  • TAM481 Giant cell arthritis (GCA)
  • TAM331 Non-IgE Cows Milk Protein Allergy Guidance 
  • TAM135 Acute coronary care syndrome
  • AMT101 Amikacin
  • AMT152 Influenza treatment
  • Urinary tract (UTI)
  • TAM508 Pre-Diabetes and type 2 referrals

Removed guidance 

  • COVID078 Emergency management of tracheostomy patient on LTV 
  • COVID019 Rheumatology COVID-19
  • COVID102 Anticoagulant COVID-19
  • COVID004 Cancer COVID-19
  • COVID052 End of life Acute COVID-19
  • COVID006 Diabetes COVID-19 
  • TAM302 Management following colposcopy 
  • TAM299 Cervical smear recall 
  • TAM387 Incontinence dermatitis
  • FCR110 Inner Moray Firth Investigation and Treatment Room Service 
  • COVID021 SKIN COVID-19
  • COVID020 Sexual Health
  • COVID013 Mental Health COVID-19

February 2023:

NB this section is being updated on a daily basis throughout the month.

New guidance

  • Refugee and asylum seeker support
  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure

Amended guidance 

  • TAM310 GP Out of Hours HSCP
  • COVID111 Non hospitalised patients with symptomatic COVID-19 infection 
  • COVID039 Aeroso generating procedures
  • TAM185 Ophthalmology diagnosis/flowcharts 
  • TAM148 Achieving control in type 2 diabetes 
  • TAM UTI guidance 

March 2023:

New guidance

  • ADHD pilot pathway

Updated guidance

  • Stress and distress in dementia

Removed guidance

  • Incontinence dermatitis
  • Skin COVID-19
  • Sexual Health COVID-19

April 2023:

New guidance

  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure
  • VTEP guidance: New Craigs

Updated guidance

  • Aerosol generating procedures COVID-19
  • Eyes
  • Genital tract
  • Highest Risk List: COVID-19
  • HIV pre-exposure prophylaxis PrEP
  • Infective endocarditis
  • Influenza treatment
  • Microbiology susceptibility reporting
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Smoking cessation
  • Ultrasound referral guidelines
    • Neck lump added

Removed guidance

  • Long term ventilation: Primary Care: COVID-19

May 2023:

New guidance

  • ECG monitoring of patient on drugs known to prolong the QT interval
  • Gender identity guidance
  • Palpable cervical lymph nodes (paediatrics)
  • Ultrasound follow-up of gall bladder polyp
  • Vancomycin in haemodiafiltration

Updated guidance

  • Chronic and persistent pain

June 2023:

Updated guidance

  • Hyperkalaemia
  • FAQ for GP CT Referral for Cancer
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy
  • Ophthalmology referral guidelines, including Out of Hours
  • Ophthalmology emergency admission protocol: Raigmore and NTC
  • Orbital cellulitis
  • Lower limb lymphoedema
  • Upper Limb lymphoedema
  • Age-related macular degeneration (nhsh.scot)
  • Patient information - Stroke (nhsh.scot)
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy (nhsh.scot)
  • FAQ for GP CT Referral for Cancer Pathway (nhsh.scot)
  • Referral to Community Diabetes Specialist Nurses (nhsh.scot)

July 2023:

Updated guidance

  • Sayana Press
  • Armed forces and veterans 

August 2023:

New Guidelines

  • Major haemorrhage protocol 

Updated Guidelines 

  • Computerised cognitive behaviour (cCBT) 
  • Referral to community diabetes
  • FAQ for GP CT Referral for cancer pathway 
  • Imaging pathway for Primary Care direct access
  • Age related macular degeneration 
  • Patient information stroke 
  • Hyperkalaemia
  • Colorectal investigation and referral
  • Incorrect use of combined hormonal contraception 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke 
  • Adrenarche
  • Sleep onset difficulties 

September 2023:

New guidance:

  • Oral buprenorphine in opioid dependence (Guidelines) 
  • Medication assisted treatment (MAT) (Guidelines)
  • Serotonin syndrome (Guidelines)

Updated Guidance:

  • Malignant spinal cord compression
  • Uncomplicated chlamydia in Primary Care
  • Patient information stroke 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke
  • Management of children under 16yrs under the influence of drugs/alcohol 
  • Improving the Safety of Patients with a Tracheostomy
  • Ultrasound scan (USS) referral guidelines 

October 2023:

New guidance

  • Personality disorder integrated care pathway

Updated guidance

  • Prolonged seizure / status epilepticus in adults (Primary Care)
  • Osteoporosis
  • Computerised cognitive behavioural therapy (cCBT) 
  • Glucose monitoring
  • Red eye
  • Gender identity guidance 
  • Corticosteroids (dexamethasone, prednisolone and hydrocortisone for patients confirmed SARS-CoV-2 infection
  • Acute otitis media 
  • Acute otitis externa
  • Tuberculosis
  • Acute Coronary Syndrome
  • Emergency contraception 
  • Heart Failure assessment and investigations
  • Heat Failure diagnosis 
  • Heart Failure Medical management
  • Heart Failure Management of decompensation 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection
  • Lymphopenia assessment
  • ED Stroke Thrombolysis 
  • Ophthalmology referral guidelines, including Out of Hours 
  • Treatment COVID19
  • Antivirals and neutralising monoclonal antibodies COVID19
  • Hospital in-patient Tocilixumab and Sarilumab
  • Generalised anxiety disorder
  • Depression

November2023: 

Updated Guidance

  • Gender identity guidance (Guidelines) | Right Decisions (scot.nhs.uk)
  • Acute coronary syndrome
  • Highland Eating Disorder Service (HEDS) & Medical Emergency Eating Disorder (MEED)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Chronic Kidney Disease 
  • Acute Kidney Injury
  • Polycythaemia erythrocytosis
  • Psychotic Disorders
  • Thrombocytosis
  • Post-menopausal bleeding

December 2023: 

Updated Guidance

  • Feeling of lump in throat
  • Vascular
  • Treatment COVD19
  • Female urinary incontinence

2022

September 2022:

New guidance:

  • Short synacthen test
  • Resuscitation
  • Hypercalcaemia
  • Plasma metanephrines measurement
  • Delirium management
  • Child healthy weight
  • Faecal incontinence
  • Investigation of primary hyperaldosteronism

Updated guidance:

  • SGLT2 inhibitors type 2 diabetes

Guidance removed:

  • Toddler and young children; food, mood and health guidance

October 2022:

New guidance:

  • Colorectal secondary guidance

Updated guidance:

  • Testosterone replacement in menopause TAM492 
  • Gestational diabetes
  • Computerised cognitive behaviour (cCbt)
  • Folate testing and management
  • B12 deficiency testing and management
  • Children empirical antibiotic therapy
  • Intermittent claudication/critical ischaemia
  • Baricitinib for adults and children aged 2 years and older
  • Clostridium dificile
  • NTproBNP
  • Pre diabetes and type 2 diabetes referrals

Guidance removed:

  • Toddler and young children food mood and health guidance 

 

November 2022:

New guidance:

  • Bronchiolitis 
  • Emergency admission of adults with acute constipation
  • Groin hernia pathway 
  • Gallstone disease 
  • Anti reflux surgery

Updated guidance:

  • Amputation pain Raigmore
  • Ketamine
  • Teicoplanin
  • Gentamicin dosing in infective endocarditis in adults 
  • Naloxone and managing opioid
  • Post operative nausea and vomiting
  • Patient controlled analgesia PCA 
  • Subcutaneous opioid
  • Epidural analgesia
  • Local anaesthetic infusion
  • Wet legs lymphorrehoea

Guidance removed: 

  • None 

December 2022:

New Guidance: 

  • Silver Diamine fluoride
  • Bronchiolitis 
  • Raigmore emergency ophthalmology admission protocol

Updated Guidance: 

  • Pre diabetes and type 2 diabetes referrals
  • Testosterone replacement in menopause
  • Gentamicin
  • Subcutaneous Methotrexate
  • Highland eating disorder (HEDS) and MEED 
  • Subcutaneous opioids
  • Acute pain management in adults with renal impairment
  • Epidural analgesia 
  • Assessing vascular status
  • Wet legs lymphorrhoea
  • Ketamine infusion
  • Amputation
  • Pain assessment
  • Pain controlled analgesia
  • Post operative nausea and vomiting 
  • Naloxone and managing opioid
  • Local anaesthetic infusion 

Removed guidance: 

  • Information for patients, carers and families 
  • Treatment of medically unwell patients with anorexia nervosa 
  • MARSIPAN checklist 
  • Summary of a dieticians role 
  • Increased levels of care 

TEMPLATE FOR Latest updates

New Guidance:

  • Items will be added when published. 

Major updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.

  • Items will be added when published. 

Minor updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.
These items will be ratified at the next TAMSG. 


Reviewed with no changes: 

  • Items will be added when published. 

Removed Guidance:

  • Items will be added when removed.